Healthy Skepticism Library item: 7961
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Wang JC.
Beyond DTC: what to do if FDA scales back DTC advertising
Pharmaceutical Executive 1999 Jul; 19:58-60
Abstract:
The pros and cons of direct to consumer advertising are discussed as a result of letters received by the U.S. Food and Drug Administration’s (FDA) Division of Drug Marketing, Advertising and Communications (DDMAC) with alternative ways to reach patients through mass media.